PellePharm Initiates Phase 2 Clinical Trial Of Patidegib Topical Gel For People With High Frequency Basal Cell Carcinoma

Wednesday, January 8, 2020 1 min read

Key Takeaway: PellePharm Initiates Phase 2 Clinical Trial Of Patidegib Topical Gel For People With High Frequency Basal Cell Carcinoma

Full Press Release Details

PellePharm Initiates Phase 2 Clinical Trial Of Patidegib Topical Gel For People With High Frequency Basal Cell Carcinoma.